Skip to content
cardio.webdr
ToolsSpecialtiesEchoHeart sounds
ToolsSpecialtiesEchoHeart soundsFavoritesPrivate notes
cardio.webdr

Clinical clarity, in seconds. Built for focused decisions—not data collection.

Patient inputs stay on this device.
ExploreAll toolsSpecialtiesEchocardiographyHeart sounds
Your workspaceFavoritesPrivate notesCalculation historyOffline access
PlatformAboutFAQDevelopersFeedbackContact
© 2026 CardioWebdr Clinical support, not a substitute for judgment.PrivacyTermsStorageSupportReport an issue
All tools/Metabolic And Cardiovascular Obesity Scores
Interactive worksheet4 clinical inputsPatient data not stored

FIB-4 Score Calculator (for NAFLD-related CV risk)

FIB-4 Score (for NAFLD-related CV risk): Explanation and Clinical Context The FIB-4 score is a non-invasive scoring system used to estimate liver fibrosis, particularly in patients with NAFLD. It is calculated using age, AST, ALT, and platelet count. It helps identify patients at low, intermediate, or high risk of advanced liver fibrosis, which has implications for cardiovascular risk stratification, as advanced fibr

Interactive worksheet

Clinical inputs

0/4 filled
Inputs stay on this device
Active structured worksheetActive local worksheet: mapped inputs can be completed, validated, copied, saved, and exported on this device. No numerical score is asserted unless its formula is independently reproducible.
Clinical contextWhy this tool matters and how to interpret it

Understand the result,
not just the number.

FIB-4 Score (for NAFLD-related CV risk): Explanation and Clinical Context The FIB-4 score is a non-invasive scoring system used to estimate liver fibrosis, particularly in patients with NAFLD. It is calculated using age, AST, ALT, and platelet count. It helps identify patients at low, intermediate, or high risk of advanced liver fibrosis, which has implications for cardiovascular risk stratification, as advanced fibrosis is associated with increased CV events in NAFLD.

A FIB-4 score <1.30 suggests low risk, 1.30–2.67 intermediate risk, and >2.67 high risk of advanced fibrosis. This tool assists clinicians in determining the need for further liver assessment or CV risk management in patients with NAFLD.

Evidence & references1 primary source mapped
  1. Source 1

    Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006;43(6):1317-1325. doi:10.1002/hep.21178 Koehler EM, et al. Fibrosis-4 (FIB-4) index for NAFLD: Clinical relevance in cardiovascular risk prediction. J Hepatol. 2016;64:689–696.

Clinical discussionModerated, tool-specific conversation

Loading discussion…

Moderated before publishingNever include patient identifiers.

Workspace mode

Structured worksheet

Active local worksheet: mapped inputs can be completed, validated, copied, saved, and exported on this device. No numerical score is asserted unless its formula is independently reproducible.

On this pageWorksheet Clinical context References Discussion

Privacy by default

Inputs, results, favorites, and notes remain in your browser unless you explicitly export them.

Privacy details
Report formula or content issue
Continue exploring

Related clinical tools

More in this specialty
Formula reviewed

Atherogenic Index of Plasma (AIP) Calculator

Metabolic And Cardiovascular Obesity Scores
Interactive worksheet

Lipid Accumulation Product (LAP) Calculator

Metabolic And Cardiovascular Obesity Scores
Reference

TYG Index Triglyceride Glucose Index Calculator

General
Interactive worksheet

Navy Body Fat Percentage Calculator

Metabolic And Cardiovascular Obesity Scores
Clinical structure and calculation context point directly to Source 1; additional primary references remain listed for auditability.